Results 171 to 180 of about 414,323 (331)

P1168: DURABLE REMISSION AFTER SEQUENTIAL CD19/20 CAR T-CELL “CAKE-ICING” THERAPY OCCURRED IN REFRACTORY/RELAPSED DLBCL

HemaSphere, 2023
Peihao Zheng, Fei Xue, Fan Yang, Shaomei Feng, Yuelu Guo, Hui Shi, Guoai Su, Lixia MA, Liu Rui, Biping Deng, Kai Hu, Xiaoyan Ke   +11 more
doaj   +1 more source

Cystoid Macular Edema as Manifestation of Smoldering Multiple Myeloma: A Case Report. [PDF]

J Vitreoretin Dis
Pandiri S, Meshkin RS, Chaaya C, Dorsey HG, Hoyek S, Zekavat SM, Patel NA.   +6 more
europepmc   +1 more source

A Refractory Leg Skin Ulcer Associated With Multiple Myeloma Successfully Treated With Plasma Exchange, Lenalidomide, and Dexamethasone

JEADV Clinical Practice, EarlyView.
ABSTRACT Multiple myeloma (MM) is a malignant plasma cell disorder that primarily presents with CRAB symptoms (calcium elevation, renal failure, anemia, and bone abnormalities). In rare cases, MM manifests with systemic complications like skin ulcers, which present management challenges. Here, we report a 78‐year‐old Japanese man with MM and refractory
Naoko Hattori, Yutaka Kuwatsuka, Tomoka Waseda, Daisuke Ehara, Koji Ando, Hiroyuki Murota   +5 more
wiley   +1 more source

Multiple myeloma in a young patient

Miguel Ricardo Quetzal, Jorge Soler-González   +1 more
openalex   +2 more sources

Assessment of Treatment Response in Patients With Scleromyxedema by the Double Modified Rodnan Skin Score

JEADV Clinical Practice, EarlyView.
ABSTRACT Background Scleromyxedema (SMX) is a cutaneous mucinosis characterised by an abnormal accumulation of mucin in the skin and limited treatment options. Assessment of therapy response during treatment is challenging. Objectives Patients with SMX receiving high‐dose intravenous IVIg therapy were included to assess validity of the double modified ...
Julia K. Winkler, Alexander H. Enk
wiley   +1 more source

Non-Secretory Myeloma With Non-Producing Phenotype Presented as Plasma Cell Leukaemia With Plasmablast Morphology. [PDF]

EJHaem
Xu K, Proctor I.
europepmc   +1 more source

Health‐related quality of life and disease‐specific complaints among multiple myeloma patients up to 10 yr after diagnosis: results from a population‐based study using the PROFILES registry

, 2012
Floortje Mols, Simone Oerlemans, Allert H. Vos, Ad Koster, S. Verelst, Pieter Sonneveld, Lonneke V. van de Poll‐Franse   +6 more
openalex   +2 more sources

Management of Pathological Thoracolumbar Vertebral Fractures in Patients With Multiple Myeloma: Multidisciplinary Recommendations

, 2023
Georg Osterhoff, Michael Kreinest, Thomas Kuhnt, Claudia Pohlenz, Jacques Dominik Müller-Broich, Christoph Röllig, Raphael Teipel, Max J. Scheyerer, Klaus John Schnake, Ulrich Spiegl, Alexander C. Disch, the Spine Section of the German Society for Orthopaedics and Trauma (DGOU)   +11 more
openalex   +1 more source

RTA‐408 Enhances Radiosensitivity and Inhibited Tumor Progression via JNK Pathway in Glioblastoma

The Kaohsiung Journal of Medical Sciences, EarlyView.
ABSTRACT Glioblastoma (GBM) is an aggressive brain tumor with poor prognosis owing to its high invasiveness and resistance to therapy. RTA‐408, a synthetic triterpenoid and nuclear factor erythroid 2‐related factor 2 activator, exhibits anti‐inflammatory and anti‐cancer properties; however, its effects on GBM remain unclear. This study investigated the
Hung‐Pei Tsai, Hao Qin, Yoon Bin Chong, I‐Hsiang Chen, Shih‐Hsun Kuo, Tzu‐Ting Tseng, Ann‐Shung Lieu   +6 more
wiley   +1 more source

MMSA-1 is regulated by Wnt/TCF4 and involved in multiple myeloma progression and invasion via RAS/RAF signaling pathway. [PDF]

Ann Hematol
Meng S, Liu H, Gu L, Wang J, Wang J, Zhao W.   +5 more
europepmc   +1 more source